{"entity":{"type":"insider","cik":"0001536368","url":"/insider/0001536368","json_url":"/insider/0001536368.json","name":"Kunkel Lori Anne","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":8,"first":"2017-08-23","last":"2026-07-08","span_basis":"filed_date"},"name_variants":[{"name":"Kunkel Lori Anne","source":"filing","n_filings":8,"first_seen":"2017-08-23","last_seen":"2026-07-08"}],"transactions":[{"id":5906548,"accession":"0001536368-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001536368-26-000007","line_url":"/filing/0001536368-26-000007","is_derivative":false,"issuer_cik":"0001536368","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001536368","owner_cik":"0001536368","owner_name":"Kunkel Lori Anne","owner_display_name":"Kunkel Lori Anne","owner_url":"/insider/0001536368","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":50.49032512,"price_display":"50.49","price_state":"stated","total_value":504903.2512,"total_display":"504,903.25","total_whole":"504,903","shares_owned_after":41884.0,"shares_owned_after_display":"41,884","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-08","scope":"insider","n_lines":2},{"id":5947235,"accession":"0001536368-26-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001536368-26-000004","line_url":"/filing/0001536368-26-000004","is_derivative":false,"issuer_cik":"0001536368","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001536368","owner_cik":"0001536368","owner_name":"Kunkel Lori Anne","owner_display_name":"Kunkel Lori Anne","owner_url":"/insider/0001536368","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":34.53513515,"price_display":"34.54","price_state":"stated","total_value":345351.3515,"total_display":"345,351.35","total_whole":"345,351","shares_owned_after":54105.0,"shares_owned_after_display":"54,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-05","filed_date":"2026-06-09","scope":"insider","n_lines":3},{"id":8723854,"accession":"0001209191-19-005351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-005351","line_url":"/filing/0001209191-19-005351#line-1","is_derivative":false,"issuer_cik":"0001108205","issuer_name":"CURIS INC","issuer_ticker":"CRIS","issuer_name_source":null,"issuer_url":"/issuer/0001108205","owner_cik":"0001536368","owner_name":"Kunkel Lori Anne","owner_display_name":"Kunkel Lori Anne","owner_url":"/insider/0001536368","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14800.0,"shares_display":"14,800","price_per_share":1.0528,"price_display":"1.05","price_state":"stated","total_value":15581.44,"total_display":"15,581.44","total_whole":"15,581","shares_owned_after":22200.0,"shares_owned_after_display":"22,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-23","filed_date":"2019-01-25","scope":"insider"},{"id":6449455,"accession":"0001567619-18-003657","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-18-003657","line_url":"/filing/0001567619-18-003657","is_derivative":false,"issuer_cik":"0001536368","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001536368","owner_cik":"0001536368","owner_name":"Kunkel Lori Anne","owner_display_name":"Kunkel Lori Anne","owner_url":"/insider/0001536368","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":170.36582,"price_display":"170.37","price_state":"stated","total_value":851829.1,"total_display":"851,829.10","total_whole":"851,829","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-01","filed_date":"2018-10-03","scope":"insider","n_lines":2},{"id":6066396,"accession":"0001140361-18-028996","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001140361-18-028996","line_url":"/filing/0001140361-18-028996","is_derivative":false,"issuer_cik":"0001536368","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001536368","owner_cik":"0001536368","owner_name":"Kunkel Lori Anne","owner_display_name":"Kunkel Lori Anne","owner_url":"/insider/0001536368","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6840.0,"shares_display":"6,840","price_per_share":176.85517554093568,"price_display":"176.86","price_state":"stated","total_value":1209689.4007,"total_display":"1,209,689.40","total_whole":"1,209,689","shares_owned_after":4.0,"shares_owned_after_display":"4","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-15","filed_date":"2018-06-18","scope":"insider","n_lines":3},{"id":6066385,"accession":"0001140361-18-028996","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-18-028996","line_url":"/filing/0001140361-18-028996","is_derivative":false,"issuer_cik":"0001536368","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001536368","owner_cik":"0001536368","owner_name":"Kunkel Lori Anne","owner_display_name":"Kunkel Lori Anne","owner_url":"/insider/0001536368","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32392.0,"shares_display":"32,392","price_per_share":180.46320974314645,"price_display":"180.46","price_state":"stated","total_value":5845564.29,"total_display":"5,845,564.29","total_whole":"5,845,564","shares_owned_after":10792.0,"shares_owned_after_display":"10,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-14","filed_date":"2018-06-18","scope":"insider","n_lines":3},{"id":6120731,"accession":"0001140361-18-019388","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-18-019388","line_url":"/filing/0001140361-18-019388","is_derivative":false,"issuer_cik":"0001536368","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001536368","owner_cik":"0001536368","owner_name":"Kunkel Lori Anne","owner_display_name":"Kunkel Lori Anne","owner_url":"/insider/0001536368","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":132.675656,"price_display":"132.68","price_state":"stated","total_value":663378.28,"total_display":"663,378.28","total_whole":"663,378","shares_owned_after":6940.0,"shares_owned_after_display":"6,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-20","filed_date":"2018-04-24","scope":"insider","n_lines":3},{"id":4499800,"accession":"0001140361-17-041152","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-041152","line_url":"/filing/0001140361-17-041152","is_derivative":false,"issuer_cik":"0001536368","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001536368","owner_cik":"0001536368","owner_name":"Kunkel Lori Anne","owner_display_name":"Kunkel Lori Anne","owner_url":"/insider/0001536368","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":84.914088,"price_display":"84.91","price_state":"stated","total_value":424570.44,"total_display":"424,570.44","total_whole":"424,570","shares_owned_after":12240.0,"shares_owned_after_display":"12,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-02","filed_date":"2017-11-06","scope":"insider","n_lines":3},{"id":5141353,"accession":"0001140361-17-033124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-033124","line_url":"/filing/0001140361-17-033124#line-1","is_derivative":false,"issuer_cik":"0001536368","issuer_name":"Loxo Oncology, Inc.","issuer_ticker":"LOXO","issuer_name_source":null,"issuer_url":"/issuer/0001536368","owner_cik":"0001536368","owner_name":"Kunkel Lori Anne","owner_display_name":"Kunkel Lori Anne","owner_url":"/insider/0001536368","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":75.1731,"price_display":"75.17","price_state":"stated","total_value":751731.0,"total_display":"751,731.00","total_whole":"751,731","shares_owned_after":16840.0,"shares_owned_after_display":"16,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-22","filed_date":"2017-08-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"Enliven Therapeutics, Inc.","url":"/issuer/0001672619","role":"Director","n_filings":2,"first_seen":"2026-06-09","last_seen":"2026-07-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001108205","name":"CURIS INC","url":"/issuer/0001108205","role":"Director","n_filings":1,"first_seen":"2019-01-25","last_seen":"2019-01-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001581720","name":"Loxo Oncology, Inc.","url":"/issuer/0001581720","role":"Director","n_filings":5,"first_seen":"2017-08-23","last_seen":"2018-10-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001536368","retrieved_at":"2026-08-22T10:23:36+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}